ChromaTan, Inc

📍 Ambler, United States👥 26 employees💰 Last funded Jan 2023
Biotechnology Research🌐 chromatan.com
Website LinkedIn
The future of single-use, column-free purification is here. We are dedicated to empowering biopharmaceutical manufacturers with our cutting-edge, columnless single-use continuous chromatography platform, offering enhanced flexibility, scalability, and purity, reducing downtime and resin consumption, and maximizing productivity for the cost-effective production of life-saving therapies. With more efficient process development, clinical manufacturing, and commercial manufacturing, we aim to help our customers provide the most affordable therapeutics possible to their patients. Join us for our virtual ChromaChats™ roundtables to discuss and solve challenges in the field of chromatography with other leaders, network with their peers, collaborate on projects, share successes and pitfalls, and connect with other leaders. Learn more here: https://chromatan.com/chromachats/
1
Total investors
0
Early stage
0
Mid stage
0
Late stage
—
Founded

Investors

1 investors
All
Early stage
Mid stage
Late stage
Investor geography1 country
United States
1
Frequently asked questions
Who invested in ChromaTan, Inc?
ChromaTan, Inc has 1 investors on record on gritt.io.
When did ChromaTan, Inc last raise funding?
The most recent investment in ChromaTan, Inc recorded on gritt.io was in January 2023.
What industry is ChromaTan, Inc in?
ChromaTan, Inc operates in Biotechnology Research. Find similar Biotechnology Research investors on gritt.io.
Where is ChromaTan, Inc based?
ChromaTan, Inc is headquartered in Ambler, United States.